Menu
GeneBe

SMPDL3A

sphingomyelin phosphodiesterase acid like 3A

Basic information

Region (hg38): 6:122789048-122809720

Links

ENSG00000172594NCBI:10924OMIM:610728HGNC:17389Uniprot:Q92484AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the SMPDL3A gene.

  • Inborn genetic diseases (12 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the SMPDL3A gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
12
clinvar
12
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 12 0 0

Variants in SMPDL3A

This is a list of pathogenic ClinVar variants found in the SMPDL3A region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
6-122789368-G-C not specified Uncertain significance (Jan 22, 2024)3166688
6-122789377-C-G not specified Uncertain significance (Apr 27, 2022)2286308
6-122789417-C-T not specified Uncertain significance (Aug 12, 2021)2377714
6-122795716-C-T not specified Uncertain significance (Dec 15, 2023)3166687
6-122795780-C-A not specified Uncertain significance (Jun 10, 2022)2255295
6-122795872-C-T not specified Uncertain significance (Jul 15, 2021)2218020
6-122795879-G-T not specified Uncertain significance (Feb 23, 2023)2465459
6-122796917-T-G not specified Uncertain significance (Feb 17, 2024)3166689
6-122796940-C-T not specified Uncertain significance (Mar 11, 2022)2278369
6-122801331-A-G not specified Uncertain significance (Oct 06, 2022)2317456
6-122801388-A-G not specified Uncertain significance (Mar 29, 2022)2280291
6-122803697-C-G not specified Uncertain significance (Feb 05, 2024)3166690
6-122803795-G-C not specified Uncertain significance (Dec 07, 2021)2373464
6-122804919-T-C not specified Uncertain significance (Feb 27, 2023)2490021
6-122804937-G-T not specified Uncertain significance (Jul 14, 2023)2611780
6-122805018-G-A not specified Uncertain significance (Nov 02, 2021)2341506
6-122805021-A-T not specified Uncertain significance (Dec 19, 2023)3166691
6-122806328-C-G not specified Uncertain significance (Oct 05, 2023)3166686

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
SMPDL3Aprotein_codingprotein_codingENST00000368440 820551
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
6.28e-210.00012012548902591257480.00103
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.1552252320.9710.00001042986
Missense in Polyphen8998.3160.905251242
Synonymous0.6078087.20.9170.00000417836
Loss of Function-1.362720.41.338.60e-7254

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.001570.00157
Ashkenazi Jewish0.000.00
East Asian0.007560.00759
Finnish0.00004620.0000462
European (Non-Finnish)0.0004860.000484
Middle Eastern0.007560.00759
South Asian0.0003620.000359
Other0.001160.00114

dbNSFP

Source: dbNSFP

Function
FUNCTION: Has in vitro nucleotide phosphodiesterase activity with nucleoside triphosphates, such as ATP (PubMed:25288789, PubMed:26783088). Has in vitro activity with p-nitrophenyl-TMP (PubMed:25288789). Has lower activity with nucleoside diphosphates, and no activity with nucleoside monophosphates (PubMed:25288789, PubMed:26783088). Has in vitro activity with CDP-choline, giving rise to CMP and phosphocholine. Has in vitro activity with CDP-ethanolamine (PubMed:26783088). Does not have sphingomyelin phosphodiesterase activity (PubMed:25288789, PubMed:26783088). {ECO:0000269|PubMed:25288789, ECO:0000269|PubMed:26783088}.;

Recessive Scores

pRec
0.126

Intolerance Scores

loftool
0.351
rvis_EVS
0.57
rvis_percentile_EVS
82.08

Haploinsufficiency Scores

pHI
0.0541
hipred
N
hipred_score
0.251
ghis
0.388

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.000369

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Smpdl3a
Phenotype

Gene ontology

Biological process
sphingomyelin catabolic process;nucleoside triphosphate catabolic process
Cellular component
extracellular space;extracellular exosome
Molecular function
sphingomyelin phosphodiesterase activity;protein binding;phosphoric diester hydrolase activity;zinc ion binding